Creyon Bio Appoints Industry Leader, Serge Messerlian as CEO, Leveraging Decades of Company Building and Strategic Collaborations [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Revitalized Leadership and a Refined Strategic Focus on Assets in Neuromuscular, CNS, and Immunologic Diseases to Expand Treatment Landscape Advances Tissue-Specific RNA-Targeted Oligonucleotide Therapeutic Pipeline Based on Only AI-Powered Oligo Engineering Engine SAN DIEGO, April 23, 2025 BUSINESS WIRE Creyon Bio , Inc. ("Creyon") today announced the appointment of industry leader, Serge Messerlian as Chief Executive Officer, effective immediately. Mr. Messerlian brings Creyon Bio a track record in both multinational pharmaceutical and biotechnology leadership as well as company building and strategic collaborations across a range of disease areas including hematology, oncology, immunology, and rare diseases as well as novel technology platforms. Mr. Messerlian joined Creyon's Board of Directors as Executive Chairman and Acting CEO in early fall 2024. He brings extensive experience in company building and board leadership, having served in senior roles across multiple biotech
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- 2 Recession-Proof Stocks to Watch in December [Yahoo! Finance]Yahoo! Finance
- Valerie Health raises $30 million Series A to scale “AI front offices” for physicians [Fortune]Fortune
- Johnson & Johnson: Quality Compounding, Valuations Now Do The Heavy Lifting [Seeking Alpha]Seeking Alpha
- Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter ResultsBusiness Wire
- Johnson & Johnson Remains Stable With Modest Growth Potential, BofA Says [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website